2.63

14.05% -0.43

Nexalin Technology Inc (NXL)

Overview News Price History Financials Discussions Forecast

Nexalin Technology Inc stock is traded at $2.63, with a volume of 888.09K. It is down -14.05% in the last 24 hours and down -30.79% over the past month. Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Previous Close:

$3.06

Open:

$2.7

24h Volume:

888.09K

Relative Volume:

0.55

Market Cap:

$33.83M

Revenue:

$128.60K

Net Income/Loss:

$-4.60M

P/E Ratio:

-7.5143

EPS:

-0.35

Net Cash Flow:

$-3.74M

1W Performance:

-33.59%

1M Performance:

-30.79%

6M Performance:

+139.09%

1Y Performance:

+806.90%

1-Day Range:

$2.546

$3.06

1-Week Range:

$2.546

$4.09

52-Week Range:

$0.2528

$4.4899

Nexalin Technology Inc Stock (NXL) Company Profile

Name

Nexalin Technology Inc

Sector

Healthcare (1176)

Industry

Medical Devices (148)

Phone

(832) 260-0222

Address

1776 YORKTOWN, HOUSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NXL's Discussions on Twitter

Compare NXL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXL Nexalin Technology Inc	2.63	33.83M	128.60K	-4.60M	-3.74M	-0.63
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Nexalin Technology Inc Stock (NXL) Latest News

Dec 07, 2024

Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World

Dec 07, 2024

Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN

Dec 07, 2024

Dec 06, 2024

Nexalin Technology downgraded to Hold from Buy at Maxim - MSN

Dec 06, 2024

Dec 05, 2024

Maxim Group Downgrades Nexalin Technology (NXL) - MSN

Dec 05, 2024

Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada

Dec 05, 2024

Dec 02, 2024

Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World

Dec 02, 2024

Nov 28, 2024

Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat

Nov 28, 2024

Nov 26, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - Marketscreener.com

Nov 26, 2024

Nexalin Technology announces peer-reviewed publication on DIFS technology - Nasdaq

Nov 26, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep - GlobeNewswire

Nov 26, 2024

Nexalin's Brain Stimulation Tech Breakthrough Validated in Major Medical Journal | NXL Stock News - StockTitan

Nov 26, 2024

Nov 13, 2024

Nexalin Technology stock soars to all-time high of $4.07 - Investing.com

Nov 13, 2024

Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK

Nov 13, 2024

Nov 11, 2024

Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire

Nov 11, 2024

Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan

Nov 11, 2024

Nov 10, 2024

Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance

Nov 10, 2024

Nov 08, 2024